NCT01947894View on ClinicalTrials.gov

A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

CompletedOBSERVATIONAL
Enrollment

377

Participants

Timeline

Start Date

November 20, 2013

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Growth Hormone Deficiency
Interventions
OTHER

Non Interventional Study

Non Interventional Study

Trial Locations (12)

541 85

Vastra Gotalands Regionen, Skövde

791 82

Landstinget Dalarna, Falun

413 45

Sahlgrenska University hospital, Gothenburg

291 85

Central Hospital/ Department of Medicine, Kristianstad

581 85

Universitetssjukhuset, EM-kliniken, Linköping

341 82

Ljungby Lasarettet, Ljungby

205 02

University Hospital SUS, Malmo

118 83

Landstinget i Stockholms Lan, Stockholm

171 76

Karolinska Universitetssjukhuset, Kliniken for Endokrinologi, Stockholm

751 85

Akademiska sjukhuset / Medicincentrum, Diabetes- och Endokrinsektionen, Uppsala

351 85

Medicinkliniken, Centrallasarettet Vaxjo, Vaxjo

331 85

Landstinget i Jonkopings Lan, Värnamo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01947894 - A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients | Biotech Hunter | Biotech Hunter